X

Xencor

273 employees

Xencor develops superior monoclonal antibody therapeutics to treat autoimmune disorders, asthma, allergic diseases and cancer.

Investor insights

Sectors invested in

Pharmaceutical1
Health Care1
Biopharma1

Funding rounds participated in

$118M sweet spot round size

Most of their 1 investments are in rounds between $118M and $118M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

1997

Investments made

Z

Zenas BioPharma raised $118M on November 7, 2022

Investors: Tellus BioVentures, -, Longitude Capital, Vivo Capital, Quan Capital 泉创资本, Perceptive Advisors, Wellington Management and Xencor

Funding rounds raised

Total raised

$50M

from 7 investors over 7 rounds

X

Xencor raised $15M on October 25, 2007

Investors: Merlin Nexus and Novo Nordisk Ltd

X

Xencor raised $10M on May 12, 2005

Investors: Zen Investments, LLC

X

Xencor raised $50M on November 1, 2000

Investors: Sands Brothers Asset Management, LLC, Stafford Capital Partners and Moore Capital Management

X

Xencor raised $12M on June 14, 1999

Investors: Stafford Capital Partners

FAQ